Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
posted on
Nov 02, 2020 06:23PM
Buckeyes - You would know this better than I being in the business. If they are sold as a Phase II company they would be worth say $4 billion and if they were sold as a Phase III company they would be sold for roughly 3 X's what a P II company would sell for or $12 billion. Adding 6 years to our patent in great and should mean a higher number for us. Adding 3, 7 or 20 years to a potential partners patent could be worth more to them than whatever we figure ABL is worth period.
** These are all fictitious numbers. Us your own imagination.**
As I have stated in the past, the devil will be in the details if this ever actually happens. If you see a PR that says Partnership, Deal, Sale ... read it closely 2 or 3 times before commenting.
IMO todays PR plus maybe 1 more should set the stage for something pretty significant to follow.
All IMO, dyodd
tada